Paid Clinical Trials in Corpus Christi, TX
As of June 2026, 63 paid clinical trials are recruiting in Corpus Christi, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Corpus Christi offers studies at sites including Driscoll Children's Hospital for conditions such as B Acute Lymphoblastic Leukemia, Obesity, Acute Myeloid Leukemia, Ganglioneuroblastoma, Nodular. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Corpus Christi
Trials by drug in Corpus Christi
Filter results
63 clinical trials
↓ Download CSVPhase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
North American Comfilcon A Clinical Study
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Droperidol and QTc Interval Changes in ED Patients
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
About research studies in Corpus Christi
Corpus Christi has approximately 63 recruiting research studies across a wide range of therapeutic areas. Texas hosts major cancer and cardiovascular research centers including MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and the Texas Medical Center — the largest medical complex in the world.
Top Research Study Locations in Corpus Christi
Researchers run research studies in Corpus Christi, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Driscoll Children's Hospital | B Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ganglioneuroblastoma, Nodular | 29 |
| Institute of Precision Pain Medicine | Chronic Leg Pain, Chronic Low-back Pain, Chronic Pain | 4 |
| Pinnacle Clinical Research - Corpus Christi | Liver Fibrosis, MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 3 |
| South Texas Clinical Research | Endometrial Hyperplasia, Heart Failure, Obesity | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Drs. McIntyre, Garza, Avila and Jurica, Optometrists | Ametropia, Astigmatism, Myopia | 2 |
| Arthritis Care Of Texas | Rheumatoid Arthritis, Radiographic Axial Spondyloarthritis | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| Arthritis & Osteoporosis Center of Coastal Bend | Tophaceous Gout | 1 |
| Arthritis Care of Texas - Corpus Christi | Systemic Lupus Erythematosus (SLE) | 1 |
| Brusco, Corpus Christi, TX | Hypothyroidism | 1 |
| CHRISTUS Spohn Cancer Center | Breast Cancer | 1 |
| CHRISTUS Spohn Hospital Corpus Christi-Shoreline | Emergency Department Patient, QTc Intervals Changes | 1 |
| Christus Sphon Hospital Corpus Christi-Shoreline | Peripheral Arterial Disease | 1 |
| Corpus Christi Women's Center | Diagnosis, Endometriosis | 1 |
| Drs. Mcintyre Garza Avila & Jurica | Presbyopia | 1 |
| GSK Investigational Site | Chickenpox | 1 |
| Lumos Pharma Investigational Site | Growth Hormone Deficiency (GHD) | 1 |
| Pinnacle Clinical Research | Metabolic Dysfunction-associated Steatohepatitis | 1 |
| Private Practice - Dr. Osvaldo A. Brusco | Obesity, Overweight | 1 |
| Saratoga Surgical Center | Lumbar Spinal Stenosis | 1 |
| Spinecare | Lumbar Spinal Stenosis | 1 |
| Texas Ortho Ctr of Excellence | Lumbar Spinal Stenosis | 1 |
| Texas Precision Surgery Center | Lumbar Spinal Stenosis | 1 |
| WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline | Chronic Wound Care, Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer), Diabetic Foot Ulcer | 1 |
Active & Upcoming Studies in Corpus Christi (2026)
Recruiting trials in Corpus Christi grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (14 active studies)
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia · Phase 2 · National Cancer Institute (NCI)
- A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) · Phase 2 · National Cancer Institute (NCI)
Diabetes & metabolic (10 active studies)
Neurology & pain (3 active studies)
- Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control · Boston Scientific Corporation
- Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain · Phase 3 · Saol Therapeutics Inc
Cardiovascular (2 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS · Phase 3 · DalCor Pharmaceuticals
Vaccines (1 active study)
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) · Phase 3 · Merck Sharp & Dohme LLC
Common conditions studied in Corpus Christi
- B Acute Lymphoblastic Leukemia (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Obesity (3 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Acute Myeloid Leukemia (2 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Ganglioneuroblastoma, Nodular (2 active studies). Recruiting Ganglioneuroblastoma, Nodular studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- MASH - Metabolic Dysfunction-Associated Steatohepatitis (2 active studies). Recruiting MASH - Metabolic Dysfunction-Associated Steatohepatitis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Malignant Solid Neoplasm (2 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Corpus Christi
- Children's Oncology Group
- National Cancer Institute (NCI)
- Eli Lilly and Company
- Merck Sharp & Dohme LLC
- AbbVie
Local regulations and guidelines
Clinical trials in Texas are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials run in Texas must also comply with the Texas Medical Privacy Act (TMPA), which extends federal HIPAA protections to a broader range of entities handling participant data.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Corpus Christi. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Corpus Christi
Hipa.ai aggregates every recruiting study in Corpus Christi from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Corpus Christi?
There are approximately 63 recruiting clinical trials in Corpus Christi, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Corpus Christi pay participants?
Most recruiting trials in Corpus Christi compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Corpus Christi?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Corpus Christi?
The most common conditions under active study in Corpus Christi include B Acute Lymphoblastic Leukemia (3), Obesity (3), Acute Myeloid Leukemia (2), Ganglioneuroblastoma, Nodular (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Corpus Christi?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Corpus Christi on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Corpus Christi?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Corpus Christi?
Recruiting research sites in Corpus Christi include Driscoll Children's Hospital, Institute of Precision Pain Medicine, Pinnacle Clinical Research - Corpus Christi, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Corpus Christi right now?
The largest active categories in Corpus Christi are Cancer & tumors (14), Diabetes & metabolic (10), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.